Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of ACR-2316 in Specific Advanced Solid Tumors

for
Specific Advanced Solid Tumors
Location: Boston MA, Providence RI, The Bronx NY, Fairfax VA,
Sponsor: Acrivon Therapeutics

Sex: All

Age: 18+

Code: NCT06667141

Phase 1, Phase 2, Recruiting

A Phase I Open-label Study for Subjects With Advanced Malignancies

for
Advanced Solid Malignancies
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT04136834

Phase 1, Recruiting

Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue

for
Localized Breast Cancer, Localized Prostate Cancer,
Location: Phoenix AZ
Sponsor: Arizona Oncology Services

Sex: All

Age: 18+

Code: NCT00651417

Phase 2, Recruiting

Dabrafenib and/or Trametinib Rollover Study

for
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers,
Location: Toronto
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT03340506

Phase 4, Recruiting

Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)

for
Cancer
Location: New York NY
Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 18+

Code: NCT00006199

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Boston MA, Philadelphia PA, Charlottesville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04104776

Phase 1, Phase 2, Recruiting

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

for
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation,
Location: New York NY
Sponsor: General Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04150042

Phase 1, Recruiting

Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Houston TX, Gilbert AZ
Sponsor: Adherex Technologies, Inc.

Sex: Female

Age: 18+

Code: NCT01231802

Phase 2, Recruiting

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

for
Breast Cancer, Node-positive Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06833502

Phase 2, Recruiting

Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women

for
Stage I Breast Cancer
Location: Burlington VT
Sponsor: University of Vermont

Sex: Female

Age: 65+

Code: NCT00337064

Phase 1, Phase 2, Recruiting

Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology

for
Breast Cancer
Location: Madison WI
Sponsor: LumaMed

Sex: Female

Age: 18 - 70

Code: NCT02207179

Early Phase 1, Recruiting

A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer

for
Breast Cancer, Invasive Breast Cancer
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: Female

Age: 18+

Code: NCT02333890

Phase 2, Recruiting

Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer

for
Breast Cancer
Location: Durham NC
Sponsor: National Center for Research Resources (NCRR)

Sex: Female

Age: 18 - 70+

Code: NCT00006433

Phase 2, Recruiting

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

for
Malignant Solid Neoplasm
Location: Marshalltown IA, Ames IA, Boone IA, Fort Dodge IA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04871542

Recruiting

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

for
Early-stage Breast Cancer,
Location: Boston MA, Wichita KS, Fullerton CA, Whittier CA,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04553770

Phase 2, Recruiting

Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer

for
Breast Neoplasm
Location: Hamilton
Sponsor: Juravinski Cancer Center

Sex: Female

Age: 70+

Code: NCT02065960

Phase 1, Recruiting

Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer

for
Breast Carcinoma
Location: Wilmington NC
Sponsor: Coastal Carolina Radiation Oncology

Sex: Female

Age: 50+

Code: NCT01400399

Recruiting

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

for
Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03617237

Recruiting

Behavioral Weight Loss and Exercise After Treatment (BEAT)

for
Breast Cancer
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 21 - 69

Code: NCT02052115

Recruiting

A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Mobile AL
Sponsor: Southern Cancer Center

Sex: Female

Age: 18 - 70+

Code: NCT00715832

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial